Skip to main content
Erschienen in: The Indian Journal of Pediatrics 11/2016

02.03.2016 | Review Article

Child with Jaundice and Pruritus: How to Evaluate?

verfasst von: Barath Jagadisan, Anshu Srivastava

Erschienen in: Indian Journal of Pediatrics | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Jaundice with pruritus is a manifestation of cholestasis. The defective biliary drainage causes accumulation of substances that are usually excreted in bile, which in turn causes pruritus. The exact nature of the pruritogen is under evaluation. However, lysophosphatidic acid is the current favourite. The causes of cholestasis can be broadly classified as intra or extrahepatic, with intrahepatic disorders being more often associated with pruritus. Cholestatic phase of acute viral hepatitis, progressive familial intrahepatic cholestasis, syndromic and non-syndromic paucity of intralobular bile ductules, drug induced cholestasis and sclerosing cholangitis (SC) are the common causes in children. An algorithmic approach facilitates early etiological diagnosis by careful clinical evaluation combined with investigations including gamma glutamyl transpeptidase, radiological imaging (ultrasonography, magnetic resonance cholangiopancreatography), liver biopsy and genetic analysis. Management is largely supportive and includes nutritional rehabilitation with supplement of fat soluble vitamins and calcium, stepwise therapy of pruritus with drugs (ursodeoxycholic acid, rifampicin, bile acid sequestrants and/or opioid antagonists) and biliary diversion surgery. Complications of advanced liver disease and portal hypertension need to be addressed. Liver transplantation is required in children with refractory pruritus affecting the quality of life or those with end stage liver disease. Relief of biliary obstruction by endoscopy or surgery and treatment of diseases associated with SC like histiocytosis may be rewarding. Long-term follow-up for development of complications of liver disease and hepatocellular/ cholangiocarcinoma is essential. Thus, an early diagnosis and stepwise treatment with an understanding of the pathogenesis of pruritus in cholestatic disorders may decrease morbidity and mortality.
Literatur
1.
Zurück zum Zitat European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67. European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.
2.
Zurück zum Zitat Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60:399–407.CrossRefPubMed Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60:399–407.CrossRefPubMed
3.
Zurück zum Zitat Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–82.CrossRefPubMed Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–82.CrossRefPubMed
4.
Zurück zum Zitat Samanta T, Das AK, Ganguly S. Profile of hepatitis A infection with atypical manifestations in children. Indian J Gastroenterol. 2010;29:31–3. Samanta T, Das AK, Ganguly S. Profile of hepatitis A infection with atypical manifestations in children. Indian J Gastroenterol. 2010;29:31–3.
5.
Zurück zum Zitat Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. Prolonged cholestasis following hepatitis A virus infection: revisiting the role of steroids. J Global Infect Dis. 2012;4:185–6. Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. Prolonged cholestasis following hepatitis A virus infection: revisiting the role of steroids. J Global Infect Dis. 2012;4:185–6.
6.
Zurück zum Zitat Ertekin V, Selimoğlu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J. 2003;44:939–42. Ertekin V, Selimoğlu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J. 2003;44:939–42.
7.
Zurück zum Zitat Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4:25–36.CrossRefPubMed Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4:25–36.CrossRefPubMed
8.
Zurück zum Zitat Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2008;46:241–52.CrossRefPubMed Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2008;46:241–52.CrossRefPubMed
9.
Zurück zum Zitat Kamath BM, Munoz PS, Bab N, et al. A longitudinal study to identify laboratory predictors of liver disease outcome in alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;50:526–30.CrossRefPubMedPubMedCentral Kamath BM, Munoz PS, Bab N, et al. A longitudinal study to identify laboratory predictors of liver disease outcome in alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;50:526–30.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Srivastava A, Goel D, Bolia R, Poddar U, Yachha SK. Alagille syndrome: experience of a tertiary care center in north India. Indian J Gastroenterol. 2014;33:59–62.CrossRefPubMed Srivastava A, Goel D, Bolia R, Poddar U, Yachha SK. Alagille syndrome: experience of a tertiary care center in north India. Indian J Gastroenterol. 2014;33:59–62.CrossRefPubMed
11.
Zurück zum Zitat Sinha J, Magid MS, VanHuse C, Thung SN, Suchy F, Kerkar N. Bile duct paucity in infancy. Semin Liver Dis. 2007;27:319–23.CrossRefPubMed Sinha J, Magid MS, VanHuse C, Thung SN, Suchy F, Kerkar N. Bile duct paucity in infancy. Semin Liver Dis. 2007;27:319–23.CrossRefPubMed
13.
Zurück zum Zitat Kerkar N, Miloh T. Sclerosing cholangitis: pediatric perspective. Curr Gastroenterol Rep. 2010;12:195–202.CrossRefPubMed Kerkar N, Miloh T. Sclerosing cholangitis: pediatric perspective. Curr Gastroenterol Rep. 2010;12:195–202.CrossRefPubMed
14.
Zurück zum Zitat Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl. 2011;17:925–33. Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl. 2011;17:925–33.
15.
Zurück zum Zitat Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7:239–45.CrossRefPubMed Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7:239–45.CrossRefPubMed
16.
Zurück zum Zitat Arora NK, Arora S, Ahuja A, et al. Alpha 1 antitrypsin deficiency in children with chronic liver disease in north India. Indian Pediatr. 2010;47:1015–23.CrossRefPubMed Arora NK, Arora S, Ahuja A, et al. Alpha 1 antitrypsin deficiency in children with chronic liver disease in north India. Indian Pediatr. 2010;47:1015–23.CrossRefPubMed
17.
Zurück zum Zitat Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316–21.CrossRefPubMed Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316–21.CrossRefPubMed
18.
Zurück zum Zitat Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29–36.CrossRefPubMed Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29–36.CrossRefPubMed
19.
Zurück zum Zitat Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43:S49–55.CrossRefPubMed Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43:S49–55.CrossRefPubMed
20.
Zurück zum Zitat Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzić N. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 2010;50:61–6.CrossRefPubMed Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzić N. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 2010;50:61–6.CrossRefPubMed
21.
Zurück zum Zitat Makin E, Davenport M. Understanding choledochal malformation. Arch Dis Child. 2012;97:69–72.CrossRefPubMed Makin E, Davenport M. Understanding choledochal malformation. Arch Dis Child. 2012;97:69–72.CrossRefPubMed
22.
Zurück zum Zitat Kumagi T, Drenth JP, Guttman O, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int. 2012;32:510–8.PubMed Kumagi T, Drenth JP, Guttman O, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int. 2012;32:510–8.PubMed
23.
Zurück zum Zitat Krishna RP, Lal R, Sikora SS, Yachha SK, Pal L. Unusual causes of extrahepatic biliary obstruction in children: a case series with review of literature. Pediatr Surg Int. 2008;24:183–90.CrossRefPubMed Krishna RP, Lal R, Sikora SS, Yachha SK, Pal L. Unusual causes of extrahepatic biliary obstruction in children: a case series with review of literature. Pediatr Surg Int. 2008;24:183–90.CrossRefPubMed
24.
Zurück zum Zitat Pryor JP, Volpe CM, Caty MG, Doerr RJ. Noncalculous biliary obstruction in the child and adolescent. J Am Coll Surg. 2000;191:569–78.CrossRefPubMed Pryor JP, Volpe CM, Caty MG, Doerr RJ. Noncalculous biliary obstruction in the child and adolescent. J Am Coll Surg. 2000;191:569–78.CrossRefPubMed
25.
Zurück zum Zitat Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004;8:67–81.CrossRefPubMed Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004;8:67–81.CrossRefPubMed
26.
Zurück zum Zitat Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808–14.CrossRefPubMedPubMedCentral Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808–14.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Chapman R, Fevery J, Kalloo A, et al; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78. Chapman R, Fevery J, Kalloo A, et al; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.
28.
Zurück zum Zitat Balistreri WF. Bile acid therapy in pediatric Hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24:573–89.CrossRefPubMed Balistreri WF. Bile acid therapy in pediatric Hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24:573–89.CrossRefPubMed
29.
Zurück zum Zitat Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 1997;25:519–23.CrossRefPubMed Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 1997;25:519–23.CrossRefPubMed
30.
Zurück zum Zitat Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50:323–32.PubMed Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50:323–32.PubMed
31.
Zurück zum Zitat El-Karaksy H, Mansour S, El-Sayed R, El-Raziky M, El-Koofy N, Taha G. Safety and efficacy of rifampicin in children with cholestatic pruritus. Indian J Pediatr. 2007;74:279–81.CrossRefPubMed El-Karaksy H, Mansour S, El-Sayed R, El-Raziky M, El-Koofy N, Taha G. Safety and efficacy of rifampicin in children with cholestatic pruritus. Indian J Pediatr. 2007;74:279–81.CrossRefPubMed
32.
Zurück zum Zitat Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013–6.CrossRefPubMed Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013–6.CrossRefPubMed
33.
Zurück zum Zitat Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102:544–9.CrossRefPubMed Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102:544–9.CrossRefPubMed
34.
Zurück zum Zitat Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51:787–9.CrossRefPubMed Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51:787–9.CrossRefPubMed
35.
Zurück zum Zitat Müller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol. 1998;10:865–70.CrossRefPubMed Müller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol. 1998;10:865–70.CrossRefPubMed
36.
Zurück zum Zitat Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with Alagille syndrome: the King’s college hospital experience. J Pediatr Gastroenterol Nutr. 2013;57:149–54. Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with Alagille syndrome: the King’s college hospital experience. J Pediatr Gastroenterol Nutr. 2013;57:149–54.
37.
Zurück zum Zitat O’Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005;21:1041–5.CrossRefPubMed O’Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005;21:1041–5.CrossRefPubMed
38.
Zurück zum Zitat Montero JL, Pozo JC, Barrera P, et al. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc. 2006;38:2511–3.CrossRefPubMed Montero JL, Pozo JC, Barrera P, et al. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc. 2006;38:2511–3.CrossRefPubMed
39.
Zurück zum Zitat Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2000;30:152–6.CrossRefPubMed Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2000;30:152–6.CrossRefPubMed
40.
Zurück zum Zitat Nightingale S, Lee NV. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin N Am. 2009;56:1161–83.CrossRef Nightingale S, Lee NV. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin N Am. 2009;56:1161–83.CrossRef
41.
Zurück zum Zitat Carrion AF, Bhamidimarri KR. Liver transplant for cholestatic liver diseases. Clin Liver Dis. 2013;17:345–59.CrossRefPubMed Carrion AF, Bhamidimarri KR. Liver transplant for cholestatic liver diseases. Clin Liver Dis. 2013;17:345–59.CrossRefPubMed
Metadaten
Titel
Child with Jaundice and Pruritus: How to Evaluate?
verfasst von
Barath Jagadisan
Anshu Srivastava
Publikationsdatum
02.03.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 11/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2058-6

Weitere Artikel der Ausgabe 11/2016

The Indian Journal of Pediatrics 11/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.